Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

First Vanadium, a High-Grade Primary Vanadium Project in the US

First Vanadium Corp. (FVAN:TSX.V; FVANF:OTCQB) is one of the better known vanadium companies. Its CEO, Paul Cowley, can be seen in a number of video clips that I linked to at the bottom of the page. Despite being a blue chip name, First Vanadium's market cap is just US$1...
Streetwise Reports | March 1, 2019 |

NGL Energy Partners Shares Rise 80% as the Firm Confirms 2020 Guidance

Shares of NGL Energy Partners traded higher after the company confirmed its fiscal 2020 EBITDA guidance and provided an update on current operations and capital expenditure reductions. Midstream energy firm NGL Energy Partners LP (NGL:NYSE) today provided ...
Streetwise Reports | March 20, 2020 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...
Streetwise Reports | January 6, 2020 |

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...
Streetwise Reports | February 4, 2020 |

Chinese real estate: Four ways investors can profit

SHANGHAI, The People's Republic of China - Given what you may have heard about Chinese property values in recent months, it may surprise you to learn that Chinese real estate investors are extremely value oriented. And so are the institutional investors I've run i...
Keith Fitz-Gerald | October 28, 2012 |

Help 9 cent GEN.T save lives with cancer screening

Friday, March 4, 2016 | www.tickertrax.com | Help 9 Cent GEN.T Save Lives with Cancer Screening By Danny Deadlock, TickerTrax Note : I have been working on this report all day (s...
Danny Deadlock | March 4, 2016 |

How a world class helium discovery in Minnesota was made by chance

The following is a transcription of the above video, and The Market Online has edited it for clarity . Our next company is Pulsar Helium Inc. (TSXV: PLSR) , a company dedicated to defining and developing primary helium assets. President and CEO Thomas Abraham-...
Lyndsay Malchuk | June 17, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Precious Metals Miner Reevaluates Nevada Operations After Q1/19 Miss

The reasons for the miss and possible paths forward were outlined in a ROTH Capital Partners report. In a May 9 research note, analyst Jake Sekelsky reported that ROTH Capital Partners reduced its target price on Hecla Mining Co. (HL:NYSE) to $3 per share ...
Streetwise Reports | May 21, 2019 |
1 2 3 4 5 6 7 8 9 10 ...